Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, indicating an update to the page, and the previous revision v3.6.4 was removed from the visible history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study's record history now includes a new Revision: v3.6.4 entry, replacing the previous Revision: v3.6.3 in the version list.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe record history now shows a new revision entry: v3.6.3, replacing the previous v3.6.1. This represents a minor metadata update to the study's record version on the ClinicalTrials.gov page.SummaryDifference0.1%

- Check49 days agoChange DetectedRecord history now includes a new release entry 'Revision: v3.6.1' and removes the prior 'Revision: v3.6.0'. This reflects a minor software version update in the page's release-tracking metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study record history gains a new version entry: Revision v3.6.0, replacing the previous v3.5.5. This update reflects the page's release version in the history.SummaryDifference0.6%

- Check85 days agoChange DetectedThe record history adds a new revision entry labeled v3.5.4 and removes the previous v3.5.3, indicating an updated revision of the study record.SummaryDifference0.1%

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.